CDK1 and cholangiocarcinoma: Pharmacological inhibition of CDK1 decreased the phosphorylation level of CDK1, inhibited cell proliferation and invasion, and arrested the cell cycle at the G1 or G2/M phase in human cholangiocarcinoma cell lines [35].